Institution statistics

BAYER AG - Germany 

Ranking results:

Past rankings:
2019
Criterium:Position:
Overall Score:300-400
Total Project Funding per Partner:> 1000
Total Number of Projects:200-300
2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):800-900
2012
Criterium:Position:
Overall Score:700-800
Total Project Funding per Partner:800-900
Total Number of Projects:66
Total Project Funding:600-700
Networking Rank (Reputation):300-400
Networking Rank (Reputation):300-400
Partner Constancy:46
Project Leadership Index:75
Diversity Index:41
2011
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:600-700
Project Leadership Index:700-800
Diversity Index:700-800
2010
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:300-400
Total Number of Projects:400-500
Total Project Funding:200-300
Networking Rank (Reputation):300-400
Partner Constancy:500-600
Project Leadership Index:600-700
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:200-300
Total Project Funding per Partner:300-400
Total Number of Projects:300-400
Total Project Funding:200-300
Networking Rank (Reputation):300-400
Partner Constancy:200-300
Project Leadership Index:300-400
Diversity Index:400-500
2008
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:700-800
Project Leadership Index:700-800
Diversity Index:> 1000
2007
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Partner Constancy:500-600
Project Leadership Index:500-600
Diversity Index:> 1000
Ranking timeline:

European project participation (2000-01-01 - 2020-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 138
As coordinator: 3
As participant: 133
Sole participant: 2
Coordinator / Participant Ratio: 0.02*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2020 0 36.225.694 0 2
2019 0 119.550.151 104.388 13
2018 0 158.450.518 0 15
2017 0 110.809.331 0 8
2016 172.800 25.019.666 0 1 3
2015 5.997.550 24.228.670 1.175.350 1 7
2014 0 7.794.899 400.000 2
2013 0 42.834.903 715.041 9
2012 0 32.826.256 603.207 7
2011 0 41.526.048 309.422 10
2010 0 75.369.716 3.898.684 12
2009 17.985.409 31.152.238 2.739.859 1 8
2008 0 31.099.304 1.505.397 5
2007 0 12.571.628 529.882 2
2006 0 9.561.319 776.752 4
2005 0 47.571.512 2.189.009 8
2004 0 27.864.721 1.357.780 5
2003 0 1.701.088 60.753 1
2002 0 5.296.733 351.003 3
2001 0 2.110.100 438.314 2
2000 2.456.100 11.425.646 1.938.539 2 7
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V15
VTT TECHNICAL RESEARCH CENTRE OF FINLAND9
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE7
JANSSEN PHARMACEUTICA NV7
NOVARTIS PHARMA7
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD7
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE6
PFIZER LIMITED6
ASTRAZENECA5
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG5
DEGUSSA5
ELI LILLY AND COMPANY LIMITED5
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE5
KATHOLIEKE UNIVERSITEIT LEUVEN5
NEDERLANDSE ORGANISATIE VOOR TOEGEPAST NATUURWETENSCHAPPELIJK ONDERZOEK TNO5
SANOFIAVENTIS5
TECHNISCHE UNIVERSITEIT EINDHOVEN5
UNIVERSITY COLLEGE DUBLIN NATIONAL UNIVERSITY OF IRELAND DUBLIN5
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS4
BASF SE4
CHARITE UNIVERSITAETSMEDIZIN BERLIN4
CONSIGLIO NAZIONALE DELLE RICERCHE4
DANMARKS TEKNISKE UNIVERSITET4
DECHEMA GESELLSCHAFT FUER CHEMISCHE TECHNIK UND BIOTECHNOLOGIE E V4
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT4
KAROLINSKA INSTITUTE4
RHEINISCH WESTFAELISCHE TECHNISCHE HOCHSCHULE AACHEN4
TAKEDA DEVELOPMENT CENTRE EUROPE4
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE4
UNIVERSITEIT GENT4
UPPSALA UNIVERSITET4
ASTRAZENECA UK LIMITED3
CENTRO RICERCHE FIAT S C P A3
CHRISTIAN ALBRECHTS UNIVERSITAET ZU KIEL3
COMMISSARIAT A L'ENERGIE ATOMIQUE3
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE3
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH3
EUROPEAN MOLECULAR BIOLOGY LABORATORY3
FORSCHUNGSZENTRUM JULICH3
INSTITUT DE RECHERCHES SERVIER3
INSTITUT FUER MIKROTECHNIK MAINZ3
INSTYTUT KATALIZY I FIZYKOCHEMII POWIERZCHNI POLSKA AKADEMIA NAUK3
INVITE3
KARLSRUHER INSTITUT FUER TECHNOLOGIE3
KING'S COLLEGE LONDON3
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV3
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN3
POLITECNICO DI MILANO3
SIB INSTITUT SUISSE DE BIOINFORMATIQUE3
SIEMENS3
STICHTING LYGATURE3
STIFTELSEN SINTEF3
TECHNISCHE UNIVERSITEIT DELFT3
TEVA PHARMACEUTICAL INDUSTRIES LIMITED3
THE UNIVERSITY OF MANCHESTER3
TTOPSTART BV3
UCB BIOPHARMA3
UNIVERSITA DEGLI STUDI DI GENOVA3
UNIVERSITAET PADERBORN3
UNIVERSITEIT UTRECHT3
UNIVERSITY OF COPENHAGEN3
UNIVERSITY OF DUNDEE3
UNIVERSITY OF NEWCASTLE UPON TYNE3
UNIVERSITY OF TAMPERE3
WEIZMANN INSTITUTE OF SCIENCE3
ABBVIE INC2
ACCIONA INFRAESTRUCTURAS2
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS2
ASTELLAS PHARMA EUROPE BV2
BAYER SCHWEIZ2
BRITEST LBG2
CENTRE DE RECHERCHE PUBLIC DE LA SANTE2
CHRISTIAN DE DUVE INSTITUTE OF CELLULAR PATHOLOGY2
CLINIQUES UNIVERSITAIRES SAINTLUC2
COATEMA COATING MACHINERY2
COATEX SAS2
CONSORZIO INTERUNIVERSITARIO NAZIONALE PER LA SCIENZA E TECNOLOGIA DEI MATERIALI2
DELFT UNIVERSITY OF TECHNOLOGY2
DEUTSCHES KREBSFORSCHUNGSZENTRUM2
EBERHARD KARLS UNIVERSITAET TUEBINGEN2
EHRFELD MIKROTECHNIK BTS2
ENI2
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM2
ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS2
EUROPEAN CANCER PATIENT COALITION2
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL2
EUROPEAN PATIENTS' FORUM2
F HOFFMANNLA ROCHE2
FOUNDATION FOR RESEARCH AND TECHNOLOGY HELLAS2
FRIEDRICHALEXANDERUNIVERSITAET ERLANGEN NUERNBERG2
GOETEBORGS UNIVERSITET2
GRUNENTHAL2
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT2
HEALTH AND SAFETY EXECUTIVE2
INSTITUT CURIE2
INSTITUT NATIONAL DE L'ENVIRONNEMENT INDUSTRIEL ET DES RISQUES2
INSTITUTO SUPERIOR TECNICO2
INTERUNIVERSITAIR MICRO ELECTRONICA CENTRUM VZW2
JOANNEUM RESEARCH FORSCHUNGSGESELLSCHAFT MBH2
JOHNSON MATTHEY PLC2
Constancy:

Total number of partners:975

Partner loyalty:
Frequent Partner: (> 2 projects): 268
Rare Partner: 707

Frequent / Rare Partner Ratio: 0.38

Diversity:

Categories:
Category:No:
INDUSTRY AND TECHNOLOGY21
RTD HORIZONTAL TOPICS19
SOCIAL AND ECONOMIC CONCERNS13
PROTECTING MAN AND HIS ENVIRON8
BIOLOGICAL SCIENCES7
ENERGY3
PHYSICAL AND EXACT SCIENCES2
MEASUREMENTS AND STANDARDS2

Project overview:

Start dateProjectacronymrolefundingpartners
2020-05-01EUbOPEN: Enabling and Unlocking biology in the OPEN EUbOPENparticipant27.935.00022
2020-01-01PharmaLedger PharmaLedgerparticipant8.290.69428
2019-10-01Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies Immune-Imageparticipant15.000.00022
2019-09-01Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials Trials@Homeparticipant19.036.99831
2019-09-01Collaboration for innovation: Establishment of a pan-nematode drug development platform HELPparticipant8.713.3958
2019-07-01Health.E Lighthouse Support Initiative HELoSparticipant499.4798
2019-06-01MachinE Learning Ledger Orchestration for Drug DiscoverY MELLODDYparticipant8.000.00017
2019-04-01Thrombo-inflammation in cardiovascular disease TICARDIOparticipant3.944.03810
2019-04-01Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement MOBILISE-Dparticipant25.395.89734
2019-03-01EBiSC2 – A sustainable European Bank for induced pluripotent Stem Cells EBiSC2participant4.599.64816
2019-03-01A multidisciplinary approach towards sustainable improvement in rare diseases care uniting Europe's top class vascular research to find new treatment strategies for vascular anomalies V.A. Cureparticipant3.792.13617
2019-03-01Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts IMMUcanparticipant17.830.00028
2019-03-01CARdiomyopathy in type 2 DIAbetes mellitus CARDIATEAMparticipant6.700.00021
2019-01-01FAIRplus FAIRplusparticipant3.996.15022
2019-01-01A European standardization framework for data integration and data-driven in silico models for personalized medicine EU-STANDS4PMparticipant2.042.41116
2018-12-01European Screening Centre; Unique Library for Attractive Biology ESCulabparticipant18.249.99320
2018-11-01European Health Data and Evidence Network EHDENparticipant14.105.75022
2018-09-01Quantitative T cell Immunology and Immunotherapy QuanTIIparticipant3.923.65310
2018-09-01Ensuring the future of EUPATI beyond 2020 EFOEUPATIparticipant365.24312
2018-07-01Research empowerment on solute carriers (ReSOLUTE) ReSOLUTEparticipant12.000.00014
2018-06-01The GetReal Initiative GetReal Initiativeparticipant1.750.00017
2018-05-01conect4children (COllaborative Network for European Clinical Trials For Children) c4cparticipant67.000.00048
2018-05-01RustWatch: A European early-warning system for wheat rust diseases RUSTWATCHparticipant4.999.99925
2018-05-01Prostate Cancer DIagnOsis and TreatmeNt Enhancement through the Power of Big Data in EuRope PIONEERparticipant6.000.00035
2018-05-01Integrated control and sensing platform for biopharmaceutical cultivation process high-throughput development and production iConsensusparticipant4.700.00019
2018-04-01Improving the care of patients suffering from acute or chronic pain IMI-PainCareparticipant11.225.27140
2018-03-01Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes. PARADIGMparticipant4.498.93134
2018-01-01Combatting the CardioRenal Syndrome: towards an integrative Analysis to reduce cardiovascular burden in chronic kidney disease CaReSyAnparticipant2.795.34616
2018-01-01Super-resolution optical microscopy of nanosized pore dynamics in endothelial cells DeLIVERparticipant3.728.51314
2018-01-01Meiotic Control of Recombination in Crops MEICOMparticipant3.107.82019
2017-09-01Enhacing TRANslational SAFEty Assessment through Integrative Knowledge Management eTRANSAFEparticipant20.000.00027
2017-09-01Develop and validate appropriate and acceptable outcome measures in intermediate age-related macular degeneration for future interventional clinical trials - Sofia ref.: 116076 MACUSTARparticipant8.025.00013
2017-03-01Big Data 4 Better Hearts - Sofia ref.: 116074 BigData Heartparticipant9.664.97019
2017-02-01Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055 DO-ITparticipant3.549.83336
2017-01-01Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106 IB4SD-TRISTANparticipant12.000.00021
2017-01-01Internet of Food and Farm 2020 IoF2020participant29.999.52882
2017-01-01Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026 HARMONYparticipant20.200.00053
2017-01-01ITCC Pediatric Preclinical POC Platform – Sofia ref.: 116064 ITCC-P4participant7.370.00021
2016-11-01Educational Network in Ocular Drug Delivery and Therapeutics OcuTherparticipant3.933.72918
2016-10-01Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966 PREFERparticipant6.000.00033
2016-09-01Highly Efficient and Thermotolerant Wheat HEAT-WHEATcoordinator172.8001
2016-09-01Biomarker Enterprise to Attack DKD - Sofia ref.: 115974 BEAt-DKDparticipant15.085.93731
2015-11-01Advancing Modelling for Process-Product Innovation, Optimization, Monitoring and Control in Life Science Industries ModLifeparticipant4.090.24912
2015-11-01Advancing Modelling for Process-Product Innovation, Optimization, Monitoring and Control in Life Science Industries ModLifeparticipant4.090.24912
2015-10-01European Network linking informatics and genomics of helper T cells ENLIGHT-TENparticipant3.354.68511
2015-09-01Modulation of glycolytic flux as a new approach for treatment of atherosclerosis and plaque stabilization: a multidisciplinary study MOGLYNETparticipant3.086.43613
2015-04-01Industrial Applications of Marine Enzymes: Innovative screening and expression platforms to discover and use the functional protein diversity from the sea INMAREparticipant5.999.55724
2015-01-01Improving Design, Evaluation and Analysis of early drug development Studies IDEASparticipant3.108.9398
2015-01-01Integrated Control and Sensing for Sustainable Operation of Flexible Intensified Processes CONSENScoordinator5.997.55015
2015-01-01Sustainability assessment methods and tools to support decision-making in the process industries SAMTparticipant498.55411

overview shows latest 50 from 138 projects (2000-01-01 - 2020-12-31)
A full list of projects can be found here:

Alias institution names:
  • BAYER
  • BAYER
  • BAYER
  • BAYER AG / BAYER HEALTH CARE
  • BAYER AG BAYER TECHNOLOGY SERVICES
  • BAYER AG ZWEIGNIEDERLASSUNG WITTERSWIL
  • BAYER AKTIENGESELLSCHAFT
  • BAYER ANIMAL HEALTH
  • BAYER BIOSCIENCE NV
  • BAYER CROPSCIENCE
  • BAYER CROPSCIENCE
  • BAYER CROPSCIENCE BIOLOGICS
  • BAYER CROPSCIENCE NV
  • BAYER HEALTH CARE
  • BAYER INNOVATION
  • BAYER MATERIALSCIENCE
  • BAYER PHARMA
  • BAYER PUBLIC LIMITED COMPANY
  • BAYER SAS
  • BAYER SCHERING PHARMA
  • BAYER SCHERING PHARMA AG GROUP
  • BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
  • BAYER SCHWEIZ
  • BAYER TECHNOLOGY SERVICES
  • BAYER WOOD TECHNOLOGIES

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum